Cura del fegato,
tumori del fegato
Aloe-Emodin quinone
pretreatment reduces acute liver injury induced by carbon tetrachloride.
Arosio B, Gagliano N, Fusaro LM, Parmeggiani L, Tagliabue J, Galetti P, De
Castri D, Moscheni C, Annoni G. Department of Internal Medicine, Milano
University Study and Hospital Maggiore IRCCS, Italy.
Aloe contains several active compounds including aloin, a C-glycoside that can
be hydrolyzed in the gut to form aloe-emodin anthrone which, in turn, is
auto-oxidized to the quinone aloe-emodin. On the basis of the claimed
hepatoprotective activity of some antraquinones, we studied aloe-emodin in a rat
model of carbon tetrachloride (CCl4) intoxication, since this xenobiotic induces
acute liver damage by lipid peroxidation subsequent to free radical production.
Twelve rats were treated with CCl4 (3 mg/kg) intraperitoneally and six were
protected with two intraperitoneally injections of aloe-emodin (50 mg/kg;
CCl4+aloe-emodin); six other rats were only aloe-emodin injected (aloe-emodin)
and six were untreated (control). Histological examination of the livers showed
less marked lesions in the CCl4+aloe-emodin rats than in those treated with CCl4
alone, and this was confirmed by the serum levels of
L-aspartate-2-oxoglutate-aminotransferase (394+/-38.6 UI/l in CCl4, 280+/-24.47
UI/l in CCl4+aloe-emodin rats; P<0.05). We also quantified changes in hepatic
albumin and tumour necrosis factor-alpha mRNAs. Albumin mRNA expression was
significantly lower only in the liver of CCl4 rats (P<0.05 versus control) and
was only slightly reduced in the CCl4+aloe-emodin rats. In contrast tumour
necrosis factor-alpha mRNA was significantly higher (P<0.05) in the CCl4 than
the control rats and almost equal in the CCl4+aloe-emodin, aloe-emodin and
control groups. In conclusion, aloe-emodin appears to have some protective
effect not only against hepatocyte death but also on the inflammatory response
subsequent to lipid peroxidation. PMID: 11129503
Vitamin C and aloe vera
supplementation protects from chemical hepatocarcinogenesis in the rat.
Shamaan NA, Kadir KA, Rahmat A, Ngah WZ. Department of Biochemistry and
Microbiology, Universiti Putra Malaysia, Selangor, Malaysia.
The effects of vitamin C and aloe vera gel extract supplementation on induced
hepatocarcinogenesis in male Sprague-Dawley rats (120-150 g) by
diethylnitrosamine (DEN) and 2-acetylaminofluorene (AAF) was investigated. The
severity of the carcinogenesis process was determined by measuring
gamma-glutamyl transpeptidase (GGT) and the placental form of glutathione
S-transferase (GSTP) histochemically in situ and in plasma and liver fractions.
In addition, plasma alkaline phosphatase (ALP) and liver microsomal uridine
diphosphate glucuronyl transferase (UDPGT) activity were also determined.
Administration of DEN/AAF caused an increase in the surface area and number of
enzyme-positive foci (both GGT and GSTP) compared with control. Supplementation
of vitamin C or aloe vera gel extract to the cancer-induced rats suppressed this
increase significantly (P < 0.05; P < 0.001). Increases in liver UDPGT, GGT, and
GSTP activities were also observed with cancer induction that were again
suppressed with either vitamin C or aloe vera gel supplementation. Plasma GGT in
the DEN/AAF rats were determined monthly for the duration of the experiment and
found to be reduced as early as 1 mo with aloe vera gel supplementation and 2 mo
with vitamin C supplementation. In conclusion, vitamin C and aloe vera gel
extract supplementation were found to be able to reduce the severity of chemical
hepatocarcinogenesis. PMID: 9834927
Decreased levels of
2-amino-3-methylimidazo[4,5-f]quinoline-DNA adducts in rats treated with
beta-carotene, alpha-tocopherol and freeze-dried aloe.
Uehara N, Iwahori Y, Asamoto M, Baba-Toriyama H, Iigo M, Ochiai M, Nagao M,
Nakayama M, Degawa M, Matsumoto K, Hirono I, Beppu H, Fujita K, Tsuda H.
Chemotherapy Division, National Cancer Center Research Institute, Tokyo, Japan.
To assess mechanisms of chemoprevention of hepatocarcinogenesis by
trans-beta-carotene (beta-C), DL-alpha-tocopherol (alpha-T), and freeze-dried
whole leaves of Kidachi aloe (Aloe), formation of 2-amino-3-methylimidazo[4,5-f]quinoline
(IQ)-DNA adducts was measured by 32P-post-labeling analysis, and CYP1A1 and
CYP1A2 protein levels were analyzed by ELISA. Group 1 rats were fed diet
containing 0.02% beta-C, 1.5% alpha-T or 30% Aloe over an 8-day period, while
group 2 was given basal diet alone. On day 7, all animals were subjected to
two-thirds partial hepatectomy (PH). Twelve hours after PH, they received a
single dose of the carcinogenic food pyrolysate IQ (100 mg/kg) intragastrically,
to initiate hepatocarcinogenesis. Rats were killed 6, 12, 24 and 48 h after IQ
administration. The levels of adducts, expressed as relative adduct labeling
values in rats treated with beta-C, alpha-T and Aloe, were decreased as compared
with the control group at hour 24 (36 h after PH), with a significant difference
in the case of the beta-C group (46.4% of the control value). Similarly, all
showed a tendency for decrease at hour 48. Furthermore, the levels of CYP1A2,
known to be responsible for activation of IQ, showed a significant reduction at
hour 24. It is concluded that beta-C, and possibly also alpha-T and Aloe, have
the potential to reduce IQ-DNA adduct formation, presumably as a result of
decreased formation of active metabolites. The results may explain, at least in
part, the previously observed inhibitory effects of these compounds on induction
of preneoplastic hepatocellular lesions. PMID: 8641964
Inhibition of benzo[a]pyrene-DNA
adduct formation by Aloe barbadensis Miller.
Kim HS, Lee BM. Division of Toxicology, College of Pharmacy, Sung Kyun
Kwan University, Suwon City, Kyunggi-Do, South Korea.
The antigenotoxic and chemopreventive effect of Aloe barbadensis Miller (polysaccharide
fraction) on benzo[a]pyrene (B[a]P)-DNA adducts was investigated in vitro and in
vivo. Aloe showed a time-course and dose-dependent inhibition of [3H]B[a]P-DNA
adduct formation in primary rat hepatocytes (1x10(6) cells/ml) treated with
[3H]B[a]P (4 nmol/ml). At concentrations of 0.4-250 microg/ml aloe, the binding
of [3H]B[a]P metabolites to rat hepatocyte DNA was inhibited by 9.1-47.9%. Also,
in rat hepatocytes cultured for 3-48 h with aloe (250 microg/ml) and [3H]B[a]P
(4 nmol/ml), [3H]B[a]P-DNA adducts were significantly reduced by 36% compared
with [3H]B[a]P alone. Aloe also inhibited cellular uptake of [3H]B[a]P in a
dose-dependent manner at a concentration of 0.4-250 microg/ml by 6.3-34.1%.
After a single oral administration of B[a]P to male ICR mice (10 mg/mouse),
benzo[a]pyrene diol epoxide I (BPDE-I)-DNA adduct formation and persistence for
16 days following daily treatment with aloe (50 mg/mouse) were quantitated by
enzyme-linked immunosorbent assay using monoclonal antibody 8E11. In this animal
model, BPDE-I-DNA adduct formation was significantly inhibited in various organs
(liver, kidney, forestomach and lung) (P < 0.001). When mice were pretreated
with aloe for 16 days before B[a]P treatment, inhibition of BPDE-I-DNA adduct
formation and persistence was enhanced. Glutathione S-transferase activity was
slightly increased in the liver but cytochrome P450 content was not affected by
aloe. These results suggest that the inhibitory effect of aloe on BPDE-I-DNA
adduct formation might have a chemopreventive effect by inhibition of B[a]P
absorption. PMID: 9111213
The effect of a plants mixture extract on
liver gluconeogenesis in streptozotocin induced diabetic rats.
al-Awadi F, Fatania H, Shamte U.
Department of Biochemistry, Faculty of Medicine, Kuwait
University, Safat.
We have previously reported on plant mixture extract comprising
of Nigella sativa, Myrrh, Gum Olibanum, Gum Asafoetida and Aloe to have a blood
glucose lowering effect. The present study with streptozotocin diabetic rats is
focussed on the mechanism of action, specifically on a) hepatic gluconeogenesis
b) activity of key gluconeogenic enzymes, pyruvate carboxylase (PC) and
phosphoenol-pyruvate carboxykinase (PEPCK). Similar studies using a biguanide,
phenformin, have been conducted to compare the mode of action of these two
compounds. The blood glucose levels (mean +/- SEM) before and after treatment
with the plants extract were (16.7 +/- 1.7 mmol/L and 8.5 +/- 1.3 mmol/L) and
with phenformin (15.1 +/- 1.3 mmol/L and 10.7 +/- 1.5 mmol/L). The rate of
gluconeogenesis in isolated hepatocytes as well as activity of PC and PEPCK in
liver homogenates is significantly lowered following treatment with the plants
extract. Although phenformin also lowers blood glucose, it does not affect
hepatic gluconeogenesis under stated experimental conditions. It is concluded
that the anti-diabetic action of the plants extract may, at least partly, be
mediated through decreased hepatic gluconeogenesis. The extract may prove to be
a useful therapeutic agent in the treatment of non-insulin dependent diabetes
mellitus (NIDDM). PMID: 1842751
Tumori solidi incurabili,
gastrointestinali, al seno, al cervello (glioblastoma)
Biotherapy with the pineal immunomodulating
hormone melatonin versus melatonin plus aloe vera in untreatable advanced solid
neoplasms.
Lissoni P, Giani L, Zerbini S, Trabattoni P, Rovelli F. Division of
Radiation Oncology, San Gerardo Hospital, Monza, Milan, Italy.
The possibility of natural cancer therapy has been recently suggested by
advances in the knowledge of tumor immunobiology. Either cytokines such as IL-2,
or neurohormones, such as the pineal indole melatonin (MLT), may activate
anticancer immunity. In addition, immunomodulating substances have also been
isolated from plants, particularly from Aloe vera. Preliminary clinical studies
had already shown that MLT may induce some benefits in untreatable metastatic
solid tumor patients, whereas, for the time being, no clinical trial has been
performed with aloe products. We have carried out a clinical study to evaluate
whether the concomitant administration of aloe may enhance the therapeutic
results of MLT in patients with advanced solid tumors for whom no effective
standard anticancer therapies are available. The study included 50 patients
suffering from lung cancer, gastrointestinal tract tumors, breast cancer or
brain glioblastoma, who were treated with MLT alone (20 mg/day orally in the
dark period) or MLT plus A. vera tincture (1 ml twice/day). A partial response
(PR) was achieved in 2/24 patients treated with MLT plus aloe and in none of the
patients treated with MLT alone. Stable disease (SD) was achieved in 12/24 and
in 7/26 patients treated with MLT plus aloe or MLT alone, respectively.
Therefore, the percentage of nonprogressing patients (PR + SD) was significantly
higher in the group treated with MLT plus aloe than in the MLT gorup (14/24 vs.
7/26, p < 0.05). The percent 1-year survival was significantly higher in
patients treated with MLT plus aloe (9/24 vs. 4/26, p < 0.05). Both treatments
were well tolerated. This preliminary study would suggest that natural cancer
therapy with MLT plus A. vera extracts may produce some therapeutic benefits, at
least in terms of stabilization of disease and survival, in patients with
advanced solid tumors, for whom no other standard effective therapy is available. PMID: 9789122
Tumori al pancreas
Chemopreventive effects of Aloe arborescens
on N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters.
Furukawa F, Nishikawa A, Chihara T, Shimpo K,
Beppu H, Kuzuya H, Lee IS, Hirose M. Division of Pathology, Biological Safety
Research Center, National Institute of Health Sciences, 1-18-1 Kamiyoga,
Setagaya-ku, Tokyo 158-8501, Japan.
The modification effects of freeze-dried aloe
(Aloe arborescens) whole leaf powder during the initiation phase of
carcinogenesis were investigated in hamsters treated with N-nitrosobis(2-oxopropyl)amine
(BOP). Female Syrian hamsters were given four weekly subcutaneous injections of
BOP at a dose of 10mg/kg and then given 0, 1 or 5% aloe in their diet for 5
weeks. At week 54 of the experiment, all surviving animals were sacrificed and
development of neoplastic and preneoplastic lesions was assessed
histopathologically. The incidences of pancreatic adenocarcinomas, atypical
hyperplasias or total atypical hyperplasias plus adenocarcinomas were
significantly (P<0.05) decreased with BOP+5% aloe, and that of adenocarcinomas
were also significantly (P<0.05) reduced in the BOP+1% aloe as compared to the
BOP alone group. Multiplicities of pancreatic adenocarcinomas, atypical
hyperplasias or total lesions were also significantly (P<0.01 or P<0.05) lower
in the BOP+5% aloe group than with the BOP alone. Quantitative data for
neoplastic lesions in the lung, liver, gall bladder, kidney and urinary bladder
of hamsters were not significantly different among the three groups. In a
satellite experiment, pretreatment with aloe significantly (P<0.01) reduced the
formation of O6-methyldeoxyguanosine in epithelial cells of pancreatic ducts as
compared to the BOP alone value. Our results thus indicate that aloe prevents
BOP-induced pancreatic neoplasia in hamsters in relation to decreased DNA adduct
formation in the target tissue. PMID: 11867195
Antiulcera
The plant kingdom as a source
of anti-ulcer remedies.
Borrelli F, Izzo AA. Department of Experimental Pharmacology, University
of Naples 'Federico II', via D. Montesano 49, 80131 Naples, Italy.
Phytogenic agents have traditionally been used by herbalists and indigenous
healers for the prevention and treatment of peptic ulcer. This article reviews
the anti-acid/anti-peptic, gastro-protective and/or anti-ulcer properties of the
most commonly employed herbal medicines and their identified active constituents.
Botanical compounds with anti-ulcer activity include flavonoids (i.e. quercetin,
naringin, silymarin, anthocyanosides, sophoradin derivatives) saponins (i.e.
from Panax japonicus and Kochia scoparia), tannins (i.e. from Linderae
umbellatae), gums and mucilages (i.e. gum guar and myrrh). Among herbal drugs,
liquorice, aloe gel and capsicum (chilli) have been used extensively and their
clinical efficacy documented. Also, ethnomedical systems employ several plant
extracts for the treatment of peptic ulcer. Despite progress in conventional
chemistry and pharmacology in producing effective drugs, the plant kingdom might
provide a useful source of new anti-ulcer compounds for development as
pharmaceutical entities or, alternatively, as simple dietary adjuncts to
existing therapies. PMID: 11113992
Acemannan hydrogel dressing
versus saline dressing for pressure ulcers. A randomized, controlled trial.
Thomas DR, Goode PS, LaMaster K, Tennyson T. Department of Internal
Medicine, St. Louis University, MO, USA.
Aloe vera has been used for centuries as a topical treatment for various
conditions and as a cathartic. An amorphous hydrogel dressing derived from the
aloe plant (Carrasyn Gel Wound Dressing, Carrington Laboratories, Inc., Irving,
TX) is approved by the Food and Drug Administration for the management of Stages
I through IV pressure ulcers. To evaluate effectiveness of this treatment, 30
patients were randomized to receive either daily topical application of the
hydrogel study dressing (acemannan hydrogel wound dressing) or a moist saline
gauze dressing. Complete healing of the study ulcer occurred in 19 of 30
subjects (63%) during the 10-week observation period. No difference was observed
in complete healing between the experimental and the control groups (odds ratio
0.93, 95% CI 0.16, 5.2). This study indicates that the acemannan hydrogel
dressing is as effective as, but is not superior to, a moist saline gauze wound
dressing for the management of pressure ulcers. PMID: 10326343